Cambridge Investment Research Advisors, Inc. Mimedx Group, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 18,410 shares of MDXG stock, worth $167,531. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,410
Previous 20,414
9.82%
Holding current value
$167,531
Previous $141,000
22.7%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MDXG
# of Institutions
208Shares Held
98.1MCall Options Held
8KPut Options Held
65.3K-
Essex Woodlands Management, Inc. The Woodlands, TX28.2MShares$257 Million47.81% of portfolio
-
Black Rock Inc. New York, NY9.31MShares$84.8 Million0.0% of portfolio
-
Trigran Investments, Inc.7.69MShares$70 Million4.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.97MShares$63.4 Million0.0% of portfolio
-
Paradigm Capital Management Inc4.66MShares$42.4 Million1.25% of portfolio
About MIMEDX GROUP, INC.
- Ticker MDXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 113,609,000
- Market Cap $1.03B
- Description
- MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...